Heart Failure Drugs Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Drugs (Beta Blockers, ARBs, ACE inhibitors)
Report Code: TIPRE00004602 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Heart Failure Drugs Market - By Drugs
1.3.2 Heart Failure Drugs Market - By Region
1.3.2.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HEART FAILURE DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HEART FAILURE DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. HEART FAILURE DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. HEART FAILURE DRUGS - GLOBAL MARKET OVERVIEW
6.2. HEART FAILURE DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. HEART FAILURE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DRUGS
7.1. OVERVIEW
7.2. DRUGS MARKET FORECASTS AND ANALYSIS
7.3. BETA BLOCKERS
7.3.1. Overview
7.3.2. Beta Blockers Market Forecast and Analysis
7.4. ARBS
7.4.1. Overview
7.4.2. ARBs Market Forecast and Analysis
7.5. ACE INHIBITORS
7.5.1. Overview
7.5.2. ACE inhibitors Market Forecast and Analysis
8. HEART FAILURE DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Heart Failure Drugs Market Overview
8.1.2 North America Heart Failure Drugs Market Forecasts and Analysis
8.1.3 North America Heart Failure Drugs Market Forecasts and Analysis - By Drugs
8.1.4 North America Heart Failure Drugs Market Forecasts and Analysis - By Countries
8.1.4.1 United States Heart Failure Drugs Market
8.1.4.1.1 United States Heart Failure Drugs Market by Drugs
8.1.4.2 Canada Heart Failure Drugs Market
8.1.4.2.1 Canada Heart Failure Drugs Market by Drugs
8.1.4.3 Mexico Heart Failure Drugs Market
8.1.4.3.1 Mexico Heart Failure Drugs Market by Drugs
8.1.4.4 US Heart Failure Drugs Market
8.1.4.4.1 US Heart Failure Drugs Market by Drugs
8.2. EUROPE
8.2.1 Europe Heart Failure Drugs Market Overview
8.2.2 Europe Heart Failure Drugs Market Forecasts and Analysis
8.2.3 Europe Heart Failure Drugs Market Forecasts and Analysis - By Drugs
8.2.4 Europe Heart Failure Drugs Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Heart Failure Drugs Market
8.2.4.1.1 Germany Heart Failure Drugs Market by Drugs
8.2.4.2 France Heart Failure Drugs Market
8.2.4.2.1 France Heart Failure Drugs Market by Drugs
8.2.4.3 Italy Heart Failure Drugs Market
8.2.4.3.1 Italy Heart Failure Drugs Market by Drugs
8.2.4.4 Spain Heart Failure Drugs Market
8.2.4.4.1 Spain Heart Failure Drugs Market by Drugs
8.2.4.5 United Kingdom Heart Failure Drugs Market
8.2.4.5.1 United Kingdom Heart Failure Drugs Market by Drugs
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Heart Failure Drugs Market Overview
8.3.2 Asia-Pacific Heart Failure Drugs Market Forecasts and Analysis
8.3.3 Asia-Pacific Heart Failure Drugs Market Forecasts and Analysis - By Drugs
8.3.4 Asia-Pacific Heart Failure Drugs Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Heart Failure Drugs Market
8.3.4.1.1 Australia Heart Failure Drugs Market by Drugs
8.3.4.2 China Heart Failure Drugs Market
8.3.4.2.1 China Heart Failure Drugs Market by Drugs
8.3.4.3 India Heart Failure Drugs Market
8.3.4.3.1 India Heart Failure Drugs Market by Drugs
8.3.4.4 Japan Heart Failure Drugs Market
8.3.4.4.1 Japan Heart Failure Drugs Market by Drugs
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Heart Failure Drugs Market Overview
8.4.2 Middle East and Africa Heart Failure Drugs Market Forecasts and Analysis
8.4.3 Middle East and Africa Heart Failure Drugs Market Forecasts and Analysis - By Drugs
8.4.4 Middle East and Africa Heart Failure Drugs Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Heart Failure Drugs Market
8.4.4.1.1 South Africa Heart Failure Drugs Market by Drugs
8.4.4.2 Saudi Arabia Heart Failure Drugs Market
8.4.4.2.1 Saudi Arabia Heart Failure Drugs Market by Drugs
8.4.4.3 U.A.E Heart Failure Drugs Market
8.4.4.3.1 U.A.E Heart Failure Drugs Market by Drugs
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Heart Failure Drugs Market Overview
8.5.2 South and Central America Heart Failure Drugs Market Forecasts and Analysis
8.5.3 South and Central America Heart Failure Drugs Market Forecasts and Analysis - By Drugs
8.5.4 South and Central America Heart Failure Drugs Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Heart Failure Drugs Market
8.5.4.1.1 Brazil Heart Failure Drugs Market by Drugs
8.5.4.2 Argentina Heart Failure Drugs Market
8.5.4.2.1 Argentina Heart Failure Drugs Market by Drugs
9. INDUSTRY LANDSCAPE
9.1. MERGERS AND ACQUISITIONS
9.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
9.3. NEW PRODUCT LAUNCHES
9.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
10. HEART FAILURE DRUGS MARKET, KEY COMPANY PROFILES
10.1. AMGEN
10.1.1. Key Facts
10.1.2. Business Description
10.1.3. Products and Services
10.1.4. Financial Overview
10.1.5. SWOT Analysis
10.1.6. Key Developments
10.2. ASTRAZENECA
10.2.1. Key Facts
10.2.2. Business Description
10.2.3. Products and Services
10.2.4. Financial Overview
10.2.5. SWOT Analysis
10.2.6. Key Developments
10.3. BAYER
10.3.1. Key Facts
10.3.2. Business Description
10.3.3. Products and Services
10.3.4. Financial Overview
10.3.5. SWOT Analysis
10.3.6. Key Developments
10.4. NOVARTIS
10.4.1. Key Facts
10.4.2. Business Description
10.4.3. Products and Services
10.4.4. Financial Overview
10.4.5. SWOT Analysis
10.4.6. Key Developments
10.5. GILEAD
10.5.1. Key Facts
10.5.2. Business Description
10.5.3. Products and Services
10.5.4. Financial Overview
10.5.5. SWOT Analysis
10.5.6. Key Developments
10.6. GLAXOSMITHKLINE
10.6.1. Key Facts
10.6.2. Business Description
10.6.3. Products and Services
10.6.4. Financial Overview
10.6.5. SWOT Analysis
10.6.6. Key Developments
10.7. PFIZER
10.7.1. Key Facts
10.7.2. Business Description
10.7.3. Products and Services
10.7.4. Financial Overview
10.7.5. SWOT Analysis
10.7.6. Key Developments
10.8. TEVA PHARMACEUTICAL INDUSTRIES
10.8.1. Key Facts
10.8.2. Business Description
10.8.3. Products and Services
10.8.4. Financial Overview
10.8.5. SWOT Analysis
10.8.6. Key Developments
10.9. CARDURION PHARMACEUTICALS
10.9.1. Key Facts
10.9.2. Business Description
10.9.3. Products and Services
10.9.4. Financial Overview
10.9.5. SWOT Analysis
10.9.6. Key Developments
10.10. CARDIOR PHARMACEUTICALS GMBH
10.10.1. Key Facts
10.10.2. Business Description
10.10.3. Products and Services
10.10.4. Financial Overview
10.10.5. SWOT Analysis
10.10.6. Key Developments
11. APPENDIX
11.1. ABOUT THE INSIGHT PARTNERS
11.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Heart Failure Drugs Market - By Drugs
1.3.2 Heart Failure Drugs Market - By Region
1.3.2.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HEART FAILURE DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HEART FAILURE DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. HEART FAILURE DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. HEART FAILURE DRUGS - GLOBAL MARKET OVERVIEW
6.2. HEART FAILURE DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. HEART FAILURE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DRUGS
7.1. OVERVIEW
7.2. DRUGS MARKET FORECASTS AND ANALYSIS
7.3. BETA BLOCKERS
7.3.1. Overview
7.3.2. Beta Blockers Market Forecast and Analysis
7.4. ARBS
7.4.1. Overview
7.4.2. ARBs Market Forecast and Analysis
7.5. ACE INHIBITORS
7.5.1. Overview
7.5.2. ACE inhibitors Market Forecast and Analysis
8. HEART FAILURE DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Heart Failure Drugs Market Overview
8.1.2 North America Heart Failure Drugs Market Forecasts and Analysis
8.1.3 North America Heart Failure Drugs Market Forecasts and Analysis - By Drugs
8.1.4 North America Heart Failure Drugs Market Forecasts and Analysis - By Countries
8.1.4.1 United States Heart Failure Drugs Market
8.1.4.1.1 United States Heart Failure Drugs Market by Drugs
8.1.4.2 Canada Heart Failure Drugs Market
8.1.4.2.1 Canada Heart Failure Drugs Market by Drugs
8.1.4.3 Mexico Heart Failure Drugs Market
8.1.4.3.1 Mexico Heart Failure Drugs Market by Drugs
8.1.4.4 US Heart Failure Drugs Market
8.1.4.4.1 US Heart Failure Drugs Market by Drugs
8.2. EUROPE
8.2.1 Europe Heart Failure Drugs Market Overview
8.2.2 Europe Heart Failure Drugs Market Forecasts and Analysis
8.2.3 Europe Heart Failure Drugs Market Forecasts and Analysis - By Drugs
8.2.4 Europe Heart Failure Drugs Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Heart Failure Drugs Market
8.2.4.1.1 Germany Heart Failure Drugs Market by Drugs
8.2.4.2 France Heart Failure Drugs Market
8.2.4.2.1 France Heart Failure Drugs Market by Drugs
8.2.4.3 Italy Heart Failure Drugs Market
8.2.4.3.1 Italy Heart Failure Drugs Market by Drugs
8.2.4.4 Spain Heart Failure Drugs Market
8.2.4.4.1 Spain Heart Failure Drugs Market by Drugs
8.2.4.5 United Kingdom Heart Failure Drugs Market
8.2.4.5.1 United Kingdom Heart Failure Drugs Market by Drugs
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Heart Failure Drugs Market Overview
8.3.2 Asia-Pacific Heart Failure Drugs Market Forecasts and Analysis
8.3.3 Asia-Pacific Heart Failure Drugs Market Forecasts and Analysis - By Drugs
8.3.4 Asia-Pacific Heart Failure Drugs Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Heart Failure Drugs Market
8.3.4.1.1 Australia Heart Failure Drugs Market by Drugs
8.3.4.2 China Heart Failure Drugs Market
8.3.4.2.1 China Heart Failure Drugs Market by Drugs
8.3.4.3 India Heart Failure Drugs Market
8.3.4.3.1 India Heart Failure Drugs Market by Drugs
8.3.4.4 Japan Heart Failure Drugs Market
8.3.4.4.1 Japan Heart Failure Drugs Market by Drugs
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Heart Failure Drugs Market Overview
8.4.2 Middle East and Africa Heart Failure Drugs Market Forecasts and Analysis
8.4.3 Middle East and Africa Heart Failure Drugs Market Forecasts and Analysis - By Drugs
8.4.4 Middle East and Africa Heart Failure Drugs Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Heart Failure Drugs Market
8.4.4.1.1 South Africa Heart Failure Drugs Market by Drugs
8.4.4.2 Saudi Arabia Heart Failure Drugs Market
8.4.4.2.1 Saudi Arabia Heart Failure Drugs Market by Drugs
8.4.4.3 U.A.E Heart Failure Drugs Market
8.4.4.3.1 U.A.E Heart Failure Drugs Market by Drugs
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Heart Failure Drugs Market Overview
8.5.2 South and Central America Heart Failure Drugs Market Forecasts and Analysis
8.5.3 South and Central America Heart Failure Drugs Market Forecasts and Analysis - By Drugs
8.5.4 South and Central America Heart Failure Drugs Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Heart Failure Drugs Market
8.5.4.1.1 Brazil Heart Failure Drugs Market by Drugs
8.5.4.2 Argentina Heart Failure Drugs Market
8.5.4.2.1 Argentina Heart Failure Drugs Market by Drugs
9. INDUSTRY LANDSCAPE
9.1. MERGERS AND ACQUISITIONS
9.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
9.3. NEW PRODUCT LAUNCHES
9.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
10. HEART FAILURE DRUGS MARKET, KEY COMPANY PROFILES
10.1. AMGEN
10.1.1. Key Facts
10.1.2. Business Description
10.1.3. Products and Services
10.1.4. Financial Overview
10.1.5. SWOT Analysis
10.1.6. Key Developments
10.2. ASTRAZENECA
10.2.1. Key Facts
10.2.2. Business Description
10.2.3. Products and Services
10.2.4. Financial Overview
10.2.5. SWOT Analysis
10.2.6. Key Developments
10.3. BAYER
10.3.1. Key Facts
10.3.2. Business Description
10.3.3. Products and Services
10.3.4. Financial Overview
10.3.5. SWOT Analysis
10.3.6. Key Developments
10.4. NOVARTIS
10.4.1. Key Facts
10.4.2. Business Description
10.4.3. Products and Services
10.4.4. Financial Overview
10.4.5. SWOT Analysis
10.4.6. Key Developments
10.5. GILEAD
10.5.1. Key Facts
10.5.2. Business Description
10.5.3. Products and Services
10.5.4. Financial Overview
10.5.5. SWOT Analysis
10.5.6. Key Developments
10.6. GLAXOSMITHKLINE
10.6.1. Key Facts
10.6.2. Business Description
10.6.3. Products and Services
10.6.4. Financial Overview
10.6.5. SWOT Analysis
10.6.6. Key Developments
10.7. PFIZER
10.7.1. Key Facts
10.7.2. Business Description
10.7.3. Products and Services
10.7.4. Financial Overview
10.7.5. SWOT Analysis
10.7.6. Key Developments
10.8. TEVA PHARMACEUTICAL INDUSTRIES
10.8.1. Key Facts
10.8.2. Business Description
10.8.3. Products and Services
10.8.4. Financial Overview
10.8.5. SWOT Analysis
10.8.6. Key Developments
10.9. CARDURION PHARMACEUTICALS
10.9.1. Key Facts
10.9.2. Business Description
10.9.3. Products and Services
10.9.4. Financial Overview
10.9.5. SWOT Analysis
10.9.6. Key Developments
10.10. CARDIOR PHARMACEUTICALS GMBH
10.10.1. Key Facts
10.10.2. Business Description
10.10.3. Products and Services
10.10.4. Financial Overview
10.10.5. SWOT Analysis
10.10.6. Key Developments
11. APPENDIX
11.1. ABOUT THE INSIGHT PARTNERS
11.2. GLOSSARY OF TERMS
The List of Companies
- Amgen
- AstraZeneca
- Bayer
- Novartis
- Gilead
- GlaxoSmithKline
- Pfizer
- Teva Pharmaceutical industries
- Cardurion Pharmaceuticals
- Cardior Pharmaceuticals GmbH
- Amgen
- AstraZeneca
- Bayer
- Novartis
- Gilead
- GlaxoSmithKline
- Pfizer
- Teva Pharmaceutical industries
- Cardurion Pharmaceuticals
- Cardior Pharmaceuticals GmbH
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak To Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount